Morris Arlene bought COGT
August 27, 2026 · Form 4 insider transaction
Morris Arlene bought 41,927 shares of Cogent Biosciences, Inc. at $5.64 per share, a transaction worth $236.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
41,927
Price
$5.64
Total value
$236.5K
InsiderMorris Arlene
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 27, 2026
Filing dateAugust 31, 2026
Shares owned after41,927
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026.